Floatz logo

Activated T Cells

Hepatitis C

Minneapolis Veterans Affairs Medical CenterCell therapyN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Hepatitis C cohort.

Asset / SponsorPhaseRating
Daclatasvir
MTI University
Phase 4A
Ribavirin
Peking University People's Hospital
Phase 4A
Sofosbuvir
Peking University People's Hospital
Phase 4A
Pegylated Interferon Alpha2A
Tanta University
Phase 4A
Simeprevir
University of Colorado, Denver
Phase 4A

View all 50 →

Same molecule, other indications

Activated T Cells is also rated in:

relapsing-remitting multiple sclerosisDormant
CC
Indicative ·
45 / 100
View asset →
glioblastomaDormant
CC
Indicative ·
41 / 100
View asset →
Chronic Lymphocytic LeukemiaDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →